File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1101/gad.1308805
- Scopus: eid_2-s2.0-24344446438
- PMID: 16107612
- WOS: WOS:000231630100010
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis
Title | The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis |
---|---|
Authors | |
Keywords | PI3K PTEN Tumor angiogenesis Cardiovasculogenesis Endothelial cells |
Issue Date | 2005 |
Citation | Genes and Development, 2005, v. 19, n. 17, p. 2054-2065 How to Cite? |
Abstract | PTEN is an important tumor suppressor gene. Hereditary mutation of PTEN causes tumor-susceptibility diseases such as Cowden disease. We used the Cre-loxP system to generate an endothelial cell-specific mutation of Pten (Tie2CrePten) in mice. Tie2CrePtenflox/+ mice displayed enhanced tumorigenesis due to an increase in angiogenesis driven by vascular growth factors. This effect was partially dependent on the PI3K subunits p85α and p110γ. In vitro, Tie2CrePtenflox/+ endothelial cells showed enhanced proliferation/migration. Tie2CrePtenflox/flox mice died before embryonic day 11.5 (E11.5) due to bleeding and cardiac failure caused by impaired recruitment of pericytes and vascular smooth muscle cells to blood vessels, and of cardiomyocytes to the endocardium. These phenotypes depend strongly on p110γ rather than on p85α and were associated with decreased expression of Ang-1, VCAM-1, connexin 40, and ephrinB2 but increased expression of Ang-2, VEGF-A, VEGFR1, and VEGFR2. Pten is thus indispensable for normal cardiovascular morphogenesis and post-natal angiogenesis, including tumor angiogenesis. © 2005 by Cold Spring Harbor Laboratory Press. |
Persistent Identifier | http://hdl.handle.net/10722/292535 |
ISSN | 2023 Impact Factor: 7.5 2023 SCImago Journal Rankings: 5.015 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hamada, Koichi | - |
dc.contributor.author | Sasaki, Takehiko | - |
dc.contributor.author | Koni, Pandelakis A. | - |
dc.contributor.author | Natsui, Miyuki | - |
dc.contributor.author | Kishimoto, Hiroyuki | - |
dc.contributor.author | Sasaki, Junko | - |
dc.contributor.author | Yajima, Nobuyuki | - |
dc.contributor.author | Horie, Yasuo | - |
dc.contributor.author | Hasegawa, Go | - |
dc.contributor.author | Naito, Makoto | - |
dc.contributor.author | Miyazaki, Jun Ichi | - |
dc.contributor.author | Suda, Toshio | - |
dc.contributor.author | Itoh, Hiroshi | - |
dc.contributor.author | Nakao, Kazuwa | - |
dc.contributor.author | Mak, Tak Wah | - |
dc.contributor.author | Nakano, Toru | - |
dc.contributor.author | Suzuki, Akira | - |
dc.date.accessioned | 2020-11-17T14:56:41Z | - |
dc.date.available | 2020-11-17T14:56:41Z | - |
dc.date.issued | 2005 | - |
dc.identifier.citation | Genes and Development, 2005, v. 19, n. 17, p. 2054-2065 | - |
dc.identifier.issn | 0890-9369 | - |
dc.identifier.uri | http://hdl.handle.net/10722/292535 | - |
dc.description.abstract | PTEN is an important tumor suppressor gene. Hereditary mutation of PTEN causes tumor-susceptibility diseases such as Cowden disease. We used the Cre-loxP system to generate an endothelial cell-specific mutation of Pten (Tie2CrePten) in mice. Tie2CrePtenflox/+ mice displayed enhanced tumorigenesis due to an increase in angiogenesis driven by vascular growth factors. This effect was partially dependent on the PI3K subunits p85α and p110γ. In vitro, Tie2CrePtenflox/+ endothelial cells showed enhanced proliferation/migration. Tie2CrePtenflox/flox mice died before embryonic day 11.5 (E11.5) due to bleeding and cardiac failure caused by impaired recruitment of pericytes and vascular smooth muscle cells to blood vessels, and of cardiomyocytes to the endocardium. These phenotypes depend strongly on p110γ rather than on p85α and were associated with decreased expression of Ang-1, VCAM-1, connexin 40, and ephrinB2 but increased expression of Ang-2, VEGF-A, VEGFR1, and VEGFR2. Pten is thus indispensable for normal cardiovascular morphogenesis and post-natal angiogenesis, including tumor angiogenesis. © 2005 by Cold Spring Harbor Laboratory Press. | - |
dc.language | eng | - |
dc.relation.ispartof | Genes and Development | - |
dc.subject | PI3K | - |
dc.subject | PTEN | - |
dc.subject | Tumor angiogenesis | - |
dc.subject | Cardiovasculogenesis | - |
dc.subject | Endothelial cells | - |
dc.title | The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis | - |
dc.type | Article | - |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1101/gad.1308805 | - |
dc.identifier.pmid | 16107612 | - |
dc.identifier.pmcid | PMC1199575 | - |
dc.identifier.scopus | eid_2-s2.0-24344446438 | - |
dc.identifier.volume | 19 | - |
dc.identifier.issue | 17 | - |
dc.identifier.spage | 2054 | - |
dc.identifier.epage | 2065 | - |
dc.identifier.isi | WOS:000231630100010 | - |
dc.identifier.issnl | 0890-9369 | - |